Showing results (81-90 of 130) with videos related to

Sort By:
Pageof 13
Annals of Hematology|February 23, 2023
Impact of age on hospitalization and outcomes post allogeneic hematopoietic cell transplantation outcome, a single center experienceEshrak Al-Shaibani, Shiyi Chen, Carol Chen, et al.
Transplantation and Cellular Therapy|May 9, 2021
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell TransplantationMaria Queralt Salas, Eshetu G Atenafu, Arjun Datt Law, et al.
Blood Cell Therapy|January 30, 2023
High Overall and GVHD-Free Survival in Patients with Aplastic Anemia Receiving in vivo T-cell Depletion Transplants and Long-Term ComplicationsMaria Queralt Salas, Eshetu G Atenafu, Wilson Lam, et al.
Transplantation and Cellular Therapy|July 15, 2025
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute LeukemiaNihar Desai, Sergio Rodriguez-Rodriguez, Mats Remberger, et al.
JCO Oncology Practice|June 29, 2026
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic TransplantationNihar Desai, Sergio Rodriguez-Rodriguez, Carol Chen, et al.
Bone Marrow Transplantation|February 7, 2020
Dual T-cell depletion with ATG and PTCy for peripheral blood reduced intensity conditioning allo-HSCT results in very low rates of GVHDMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
European Journal of Haematology|August 27, 2019
Reduced intensity allogeneic stem cell transplant with anti-thymocyte globulin and post-transplant cyclophosphamide in acute myeloid leukemiaMaria Queralt Salas, Shruti Prem, Eshetu G Atenafu, et al.
European Journal of Haematology|January 9, 2021
Refined hepatic grading system in chronic graft-versus-host disease improves prognostic risk stratification of long-term outcomesIgor Novitzky-Basso, Saud AlHayli, Elizabeth Shin, et al.
Bone Marrow Transplantation|June 10, 2021
Efficacy and cost analysis of eltrombopag in thrombocytopenia and poor graft function post allogeneic hematopoietic cell transplantationRam Vasudevan Nampoothiri, Lina Ho, Cassandra McEwan, et al.
Transplantation and Cellular Therapy|August 14, 2023
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic SyndromeMariana Pinto Pereira, Mats Remberger, Carol Chen, et al.
Pageof 13